We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00073879
Recruitment Status : Completed
First Posted : December 11, 2003
Last Update Posted : January 29, 2015
Information provided by (Responsible Party):
Helen Heslop, Baylor College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2004
  Study Completion Date : April 2004